The activity of alternative pathways provides robustness of NADPH supply and, to some extent, compensates for the deficit of PPP flux in patients with glucose-6 phosphate dehydrogenase (G6PD) deficiency—one of the most common genetic diseases in humans [18]. The gene discussed is G6PD; the disease is hyperinsulinemic hypoglycemia, familial, 4.